Arquivos brasileiros de cardiologia
-
Arq. Bras. Cardiol. · Dec 1994
Clinical Trial[Use of tranexamic acid for bleeding control in myocardial revascularization].
To compare two groups of 80 patients undergoing to myocardial revascularization with the use of antifibrinolytic drug tranexamic acid and its efficacy in reduce bleeding and blood transfusion. ⋯ Tranexamic acid was an effective drug in bleeding control and in reducing blood transfusion in the postoperative of patients submitted to myocardial revascularization.